HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McFadden, D. W. Articles by Talamini, M. A. Search for Related Content PubMed PubMed Citation Articles by McFadden, D. W. Articles by Talamini, M. A.

Ann Thorac Surg 1989;47:477-480
© 1989 The Society of Thoracic Surgeons

---

Articles

Primary small cell carcinoma of the esophagus

^a Departments of Surgery, University of Cincinnati Medical Center, Cincinnati, Ohio, USA
^b The Johns Hopkins Hospital, Baltimore, Maryland, USA

^_* Address reprint requests to Dr McFadden, University of Cincinnati Medical Center, Department of Department of Surgery, 231 Bethesda Ave (ML 558), Cincinnati, OH 45267.

A primary small cell carcinoma of the esophagus in a 61-year-old woman was treated by transhiatal esophagectomy. The clinical data were correlated with data obtained from a review of the 129 cases reported in the world literature, thereby providing a clinical profile and suggested management strategy for this rare type of esophageal malignancy. Presenting symptoms of esophageal small cell carcinoma include dysphagia (75.3%), weight loss (38.4%), and chest pain (23.3%). Treatment regimens have included surgical intervention in 58%, radiotherapy in 10%, chemotherapy in 6%, or some combination of these in 26%. Overall survival is only 20.7 weeks after diagnosis. The fact that three fourths of affected patients had metastatic disease at the time of diagnosis leads us to recommend surgical intervention plus systemic chemotherapy in these patients.

This article has been cited by other articles:

				K. MUGURUMA, M. OHIRA, H. TANAKA, N. KUBO, Y. YAMASHITA, T. SAWADA, K. WAKASA, and K. HIRAKAWA Long-term Survival of Advanced Small Cell Carcinoma of the Esophagus after Resection: A Case Report Anticancer Res, February 1, 2013; 33(2): 595 - 600. [Abstract] [Full Text] [PDF]

				K. Chin, S. Baba, H. Hosaka, A. Ishiyama, N. Mizunuma, E. Shinozaki, M. Suenaga, T. Kozuka, Y. Seto, N. Yamamoto, et al. Irinotecan Plus Cisplatin for Therapy of Small-cell Carcinoma of the Esophagus: Report of 12 Cases from Single Institution Experience Jpn. J. Clin. Oncol., June 2, 2008; (2008) hyn041v1. [Abstract] [Full Text] [PDF]

				S. I. Hajdu and P. Tang The Saga of Carcinoid and Oat-Cell Carcinoma Ann. Clin. Lab. Sci., January 1, 2008; 38(4): 414 - 417. [Full Text] [PDF]

				G. H. Pantvaidya, C.S. Pramesh, M. S. Deshpande, N. A. Jambhekar, S. Sharma, and R. K. Deshpande Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience Ann. Thorac. Surg., December 1, 2002; 74(6): 1924 - 1927. [Abstract] [Full Text] [PDF]

				S. Yachida, K. Matsushita, H. Usuki, H. Wanibuchi, T. Maeba, and H. Maeta Long-term survival after resection for small cell carcinoma of the esophagus Ann. Thorac. Surg., August 1, 2001; 72(2): 596 - 597. [Abstract] [Full Text] [PDF]

				S. R. Craig, F. A. Carey, W. S. Walker, and E. W. J. Cameron Primary small-cell cancer of the esophagus J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 284 - 288. [Abstract] [Full Text]

				M. D. Lieberman, D. Franceschi, B. Marsan, and M. Burt Esophageal carcinomaThe unusual variants J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1138 - 1146. [Abstract] [Full Text]